No abstract available
MeSH terms
-
Adalimumab
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / immunology
-
Anti-Inflammatory Agents / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Certolizumab Pegol
-
Drug Administration Schedule
-
Drug Interactions
-
Drug Monitoring
-
Etanercept
-
Humans
-
Immunoglobulin Fab Fragments / therapeutic use
-
Immunoglobulin G / therapeutic use
-
Infliximab
-
Patient Education as Topic
-
Patient Selection
-
Polyethylene Glycols / therapeutic use
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin Fab Fragments
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Polyethylene Glycols
-
Infliximab
-
Adalimumab
-
Etanercept
-
Certolizumab Pegol